When Michael Krachon talks about Theragenics and its mission, his words carry both scientific precision and a sense of urgency. As president of the Georgia-based medical technology company, he knows the stakes could not be higher. Every decision the company makes, every isotope it produces, and every brachytherapy seed it delivers can alter a patient’s […]
